Hi [[ session.user.profile.firstName ]]

The Essential Value: IoT SEPs and the Case for Patent Pools

The future of connected cities, smart cars, and autonomous factories is well within our purview, but there is a risk of delay to this ecosystem of opportunity as industry and innovators determine the value of integral technologies that unlock a world of capabilities.

This webinar will explore the evolution and nuances of licensing wireless technologies in new internet of things (IoT) verticals, and discuss the role of licensing frameworks such as patent pools in our increasingly connected future.

Join experts from across the technology and IP industries as they share perspectives on fostering IoT innovation and value.

Speakers include:
Mathias Hellman, VP of IPR Strategy & Portfolio Management at Ericsson
Luke McLeroy, Senior VP of Business Development, Avanci
Timothy Berghuis, Chief Licensing Officer, InterDigital
Recorded May 27 2020 67 mins
Your place is confirmed,
we'll send you email reminders
Presented by
Mathias Hellman (Ericsson), Luke McLeroy (Avanci), Timothy Berghuis (InterDigital), Tom Phillips (WIPR)
Presentation preview: The Essential Value: IoT SEPs and the Case for Patent Pools
  • Channel
  • Channel profile
  • Internet Infringement Doesn't Take a Holiday Recorded: Oct 29 2020 56 mins
    Fred Felman (Appdetex), Russ Pangborn (Seed IP), Tom Phillips (WIPR)
    A year unlike any other - as 2020 winds down and the holiday season heats up, we can expect to see even more abuse of intellectual property and brands in digital channels.

    Join Russ Pangborn of Seed-IP and Fred Felman of Appdetex in a timely dialogue exploring the hallmarks of abuse in 2020, the current realities of enforcement and how those phenomena will affect brand protection professionals during the always-busy holiday season.
  • IP and R&D Trends in Biological Sequencing Recorded: Sep 28 2020 39 mins
    Karthik Subramanian (PatSnap), Shivshankar Umashankar (PatSnap), and Tom Phillips (WIPR)
    A recent study from McKinsey claims that 45% of the world’s disease burden could be addressed by biological means. With the increasing number of cancers and other rare diseases, it is no surprise that biotech innovations are on the rise.
    To supplement that, advancements in biotechnology such as next-generation sequencing techniques and personalised medicines have made the large-scale development of biological drugs easier and more cost-effective.
    The prior art, containing patents for biological gene sequences, and the claims generally include descriptions of gene sequences as a form of protection of DNA, RNA, other nucleotides and proteins.
    These patents are always claimed in relation to the sequence upon which the said drug acts. This is mostly with respect to a disease which occurs as a result of sequence mutation, or a disease which the drug is used to treat that acts upon the sequence mentioned in the claim.
    Metadata associated to a sequence claimed in a patents has therefore gained more significance than before, for both research and freedom-to-operate perspectives.
    In this webinar, we will look closely at how prior art is contributing to drug discovery, and how the trend over the last five years in the prior art landscape has made IP and R&D professionals change the way sequence searching is done.
    We also look at how artificial intelligence has helped platforms such as PatSnap Bio shift the approach to sequence searching to the next level, and meet the changing patenting landscape in biological sequencing.
  • SPCs: protection of active ingredients, new and old Recorded: Sep 9 2020 66 mins
    Joel Beevers (Potter Clarkson), Michael Pears (Potter Clarkson), Stephanie Pilkington (Potter Clarkson), Tom Phillips (LSIPR)
    Joel Beevers, Michael Pears and Stephanie Pilkington of Potter Clarkson will explore the practical impact of recent CJEU case law in Royalty Pharma (C-650/17) and Teva v Gilead (C-121/17) on what constitutes ‘protection’ of active ingredients by the basic patent in the context of supplementary protection certificates (SPCs); how patent specifications can be optimised for this purpose; and how it can influence patent filing strategies.
    They also consider the current state of play for obtaining SPCs for previously authorised active ingredients in view of the recent CJEU judgments in Abraxis (C-443/17) and Santen (C-673/18), and what options remain open to maximise exclusivity.
  • Antibody patents: maximising value in Europe and beyond Recorded: Aug 5 2020 60 mins
    Tom Leonard (Kilburn & Strode), Alison Care (Kilburn & Strode), Dave Wortley (Kilburn & Strode), Tom Phillips (WIPR)
    Antibody Patents: Maximising value in Europe and beyond

    Join antibody experts and European Patent Attorneys Tom Leonard, Alison Care and Dave Wortley of Kilburn & Strode for a 60 minute webinar discussion on the latest developments in antibody patenting on Wednesday 5th August 2020 at 4.30pm BST (8.30am West Coast, 11.30am East Coast, 5.30pm Central European Time).

    Drawing on both private practice and in-house experience, this in-depth webinar has been specifically curated for those working in the antibody field, including private practice attorneys, in-house counsel and others involved in the development and marketing of antibodies. We will explore best practice for:

    · Drafting applications, including how to maximise potential claim scope where possible and what data to include to support your claims

    · Patent filing and IP strategies, including when and where to file

    · Prosecution of global portfolios, taking into account how different patent offices examine applications relating to antibodies

    · The preparation of freedom-to-operate and landscaping opinions to best inform the business or to prepare yourself for third-party due diligence

    This webinar will run for 1 hour.
  • How to Deal with Bad Faith Trademark Registrations in China Recorded: Jul 28 2020 60 mins
    Jason Yao (Wanhuida IP), Mingming Yang (Wanhuida IP), Tom Phillips (WIPR)
    It’s extremely frustrating for brand owners, especially small and medium-sized enterprises, to realise when they plan to launch their products into the China market that their trademarks have been registered by someone else.

    This frustration is understandable, and in this webinar, we hear from those who have been vigorously pushing the Chinese legislative authorities to reform the trademark registration regulations, reforms that have recently come to fruition with many positive changes to the Trademark Office, as well as to the Trademark Law.

    This webinar will bring you the most up-to-date changes to the trademark registration system and laws in order to deal with bad faith trademark applications. We will also share with you first-hand experiences and strategies in dealing with bad faith registrations, including:

    The latest changes to the Trademark Law in China;

    How to deal with bad faith trademark registration: opposition; invalidation; cancellation; civil litigations; administrative enforcement actions; and Case study and Q&A.
  • Brand Abuse: Fighting bad actors during the pandemic Recorded: Jul 14 2020 65 mins
    Fred Felman (Appdetex), Fabricio Vayra (Perkins Coie), Peter Scott (WIPR)
    The first half of 2020 has brought dramatic changes to how we work and live, with sharp increases in remote work arrangements and use of e-commerce and mobile apps.

    Bad actors, poised to take advantage of any rising trend in business and consumer behaviour, are capitalising on the pandemic across multiple vectors as digital channels grow in importance.


    What are the implications for intellectual property and brand protection professionals, and will those implications extend beyond this crisis period? Did the recent ICANN meeting identify any changes to the availability of WHOIS or other relief for brand protection professionals?

    This webinar examines trends in online brand abuse, describing the latest scams and statistics, and recommending how you can best position your online brand protection strategy to mitigate the effects of abuse.

    Trusted brands have never been more important. This webinar will provide insight and practical guidelines so you can elevate the security posture of your brand during this period of rapid shifts and heightened risk.
  • IP Management in Times of Crisis: how to maximise impact while minimising cost Recorded: Jul 9 2020 59 mins
    Volker Spitz (Brandstock), David Llewellyn (Arm), Tom Phillips (WIPR)
    The COVID-19 crisis has had huge implications for IP management, and companies look to cut costs and secure their assets. This webinar will consider how best to protect yourself in times of crisis, how to avoid overreacting, and how to control costs while maintaining effectiveness. What does 2021 look like? And what are the long terms impacts of the crisis for brands and IP management?
  • Anti-counterfeiting strategies in Russia: fighting online threats Recorded: Jun 22 2020 51 mins
    Evgeny Alexandrov (Gorodissky & Partners), Tom Phillips (WIPR)
    Online sales create significant threats for brand owners worldwide. Many online brand protection issues in Russia and its neighbouring countries present unique challenges requiring local knowledge and specialist expertise.

    In order to ensure the highest level of protection of brands and other IP assets, a tailored approach is required with respect to each jurisdiction. We invite brand protection managers, brand owners, lawyers and other IP rights enforcement specialists to our webinar session dedicated to strategies for efficient brand protection options in Russia.
  • Domain Name Abuse: Coping with COVID-19, ICANN and GDPR Recorded: Jun 18 2020 71 mins
    Raphael Gutierrez (Uber), Faisal Shah (Appdetex), Susan Kawaguchi (Appdetex), Alex Deacon(Cole Valley)
    Intellectual property professionals are coping with a whirlwind of change. From the COVID crisis to ICANN’s reaction to GDPR, the methods for identifying and abating brand-related domain abuse have shifted radically. Join a panel of domain name experts from Uber, Appdetex, and Cole Valley Consulting in a discussion of these trends and the steps that the world’s largest brands are taking to protect their customers and their IP.
  • Preliminary Injunctions: How to Get Them, How to Avoid Them Recorded: Jun 10 2020 68 mins
    Monica Arnold (Milbank), Gary Frischling (Milbank), David Gindler (Milbank), Tom Phillips (WIPR)
    Sometimes monetary damages aren’t enough. In cases between fierce competitors—whether innovator vs innovator, or brand vs generic—an injunction at the beginning of litigation may be more valuable than monetary damages at the end.

    And for a new company with a single product, the prospect of a preliminary injunction from a well-funded rival may threaten the company’s very existence.

    This webinar will explore the strategies, arguments and evidence that have carried the day for patent holders and for accused infringers in a preliminary injunction battle.

    Among the issues to be addressed are:
    What arguments on the merits are most likely to succeed or fail?
    When are price erosion and lost market share fully compensable by money, and when do they show irreparable harm?
    Will new or different arguments be made in cases involving biosimilars, compared to small molecule drugs?
    Do the balance of hardships or the public interest ever make a difference to the outcome?

    Speakers include:
    Monica Arnold, Associate, Milbank
    Gary Frischling, Partner, Milbank
    David Gindler, Partner, Milbank
  • Best Practices for Corporate Domain Name Management in Uncertain Times Recorded: May 28 2020 59 mins
    Matt Serlin (Brandsight), Elisa Cooper (Brandsight), Tom Phillips (WIPR)
    Within the last two months, priorities for corporate domain name managers have been turned upside down. With an increase in domain name abuse and a renewed focus on cost containment, corporate domain name managers are now being presented with competing priorities that are seemingly at odds with one another.

    More than ever, corporate domain name managers are being asked to do more, with less.

    Given these changing priorities, join domain name industry experts Matt Serlin and Elisa Cooper as they share practical steps for:

    Paring domain name registrations and containing costs

    Identifying and remediating security risks

    Optimising portfolios and proving ROI



    They will also be sharing best practices for selecting service providers, designing and managing domain name programmes, and streamlining workflow.
  • The Essential Value: IoT SEPs and the Case for Patent Pools Recorded: May 27 2020 67 mins
    Mathias Hellman (Ericsson), Luke McLeroy (Avanci), Timothy Berghuis (InterDigital), Tom Phillips (WIPR)
    The future of connected cities, smart cars, and autonomous factories is well within our purview, but there is a risk of delay to this ecosystem of opportunity as industry and innovators determine the value of integral technologies that unlock a world of capabilities.

    This webinar will explore the evolution and nuances of licensing wireless technologies in new internet of things (IoT) verticals, and discuss the role of licensing frameworks such as patent pools in our increasingly connected future.

    Join experts from across the technology and IP industries as they share perspectives on fostering IoT innovation and value.

    Speakers include:
    Mathias Hellman, VP of IPR Strategy & Portfolio Management at Ericsson
    Luke McLeroy, Senior VP of Business Development, Avanci
    Timothy Berghuis, Chief Licensing Officer, InterDigital
  • Best Practices in Online Brand Protection: Changing Times, Changing Priorities Recorded: May 6 2020 62 mins
    Frederick Felman (Appdetex), and Fabricio Vayra (Perkins Coie), Tom Phillips (WIPR)
    The last few weeks have brought dramatic changes to how we work and live, with sharp increases in remote work arrangements and use of e-commerce and mobile apps.

    Bad actors, poised to take advantage of any rising trend in business and consumer behaviour, are capitalising on the pandemic across multiple vectors as digital channels grow in importance.

    What are the implications for intellectual property and brand protection professionals, and will those implications extend beyond the crisis period?

    This webinar examines trends in online brand abuse, describing the latest scams and statistics, and recommending how you can best position your online brand protection strategy to mitigate the effects of abuse.

    Trusted brands have never been more important. This webinar will provide insight and practical guidelines so you can elevate the security posture of your brand during this period of rapid shifts and heightened risk.
  • Patenting computer-implemented healthcare inventions in AI and machine learning Recorded: Apr 23 2020 52 mins
    Dr Andrew McGettrick (HGF), Tom Phillips (WIPR)
    The European Patent Office (EPO) has recognised the importance of artificial intelligence (AI) and machine learning by updating the EPO Guidelines for Examination to focus on the patentability of innovations having an AI aspect. The EPO held a conference in 2018 directed to patenting AI, testament to the impact AI is having in all areas of technology.

    It is a common misconception that computer software cannot be patented. Although not all software is patentable, software in the medical technology field is often patentable. Navigating exclusions to patentability can be a challenge with AI inventions because they can be viewed as a form of mathematical method, which are on the list of non-inventions defined by the European Patent Convention.

    Although routine implementation of AI or machine learning to solve a problem foreseeably solvable by AI is unlikely to be sufficient to obtain patent protection, it is eminently possible to obtain patent protection for AI inventions.

    This webinar will explore by example how to approach the patenting of AI inventions in the medical field and how to navigate the exclusions from patentability, including some types of computer software, pure mathematical methods and methods of diagnosis.
  • Key Considerations for a FRAND Patent Licensing Strategy - Panel Discussion Recorded: Mar 12 2020 49 mins
    Ryan Richardson (Sterne Kessler), Hongming Liu (Tencent America), Ken Seddon (The LOT Network), Andrew Schwaab (SVIPLA)
    Preceded by an introduction to The LOT Network by, CEO, Ken Seddon.

    This webinar was originally programmed as a panel discussion/presentation at Technology Patent Network North America in San Jose on March 12. In light of the continuing COVID-19 outbreak, we have postponed that event to a date to be confirmed later in 2020. In the meantime, we hope you enjoy these presentations and that you'll join us when the revised conference programme is delivered in person. All registrations for the San Jose event will be valid for the rescheduled event.
  • Patenting Artificial Intelligence: Use of Patents or Trade Secrets Recorded: Mar 12 2020 31 mins
    David Sanker, Partner, Morgan Lewis & Bockius
    Patenting Artificial Intelligence: Use of Patents or Trade Secrets

    As Innovation is now Outpacing the Law, is it Time to Devise a Broader Legal Strategy to Protect IP in AI?
    How do you Develop a Trade Secrets Strategy?

    This webinar was originally programmed as a presentation at Technology Patent Network North America in San Jose on March 12. In light of the continuing COVID-19 outbreak, we have postponed that event to a date to be confirmed later in 2020. In the meantime, we hope you enjoy these presentations and that you'll join us when the revised conference programme is delivered in person. All registrations for the San Jose event will be valid for the rescheduled event.
  • Best Practice for In-House IP Counsel: Invention Harvesting - Panel Discussion Recorded: Mar 12 2020 45 mins
    Jennifer Lane Spaith (Dorsey & Whitney), Mehul Shah (Nagra/Kudelski), Peter Jovanovic (Dell)
    This webinar was originally programmed as a panel discussion at Technology Patent Network North America in San Jose on March 12. In light of the continuing COVID-19 outbreak, we have postponed that event to a date to be confirmed later in 2020. In the meantime, we hope you enjoy these presentations and that you'll join us when the revised conference programme is delivered in person. All registrations for the San Jose event will be valid for the rescheduled event.
  • Patenting Artificial Intelligence Recorded: Feb 11 2020 58 mins
    Peter Scott (WIPR), Dr Susan Keston (HGF), Jeff Clarke (HGF)
    As patent attorneys we are trained to tease out the thoughts of a human inventor in tackling a problem. However, inventions involving artificial intelligence (AI) can present us with the challenge of an inventor explaining that with sufficient input data, the “black box” number-crunching outputs a neat solution to the problem posed.

    We are not yet at a point at which AI-powered machines and software have become untethered from the supervision of human beings. However, if you use Apple’s Siri, you are benefiting from AI-based natural language processing. Google’s DeepMind is applying AI to process raw data from the environment to emulate human learning, and AI-driven software can predict epileptic seizures with incredible accuracy.

    This webinar explores invention-spotting strategies for AI innovations. The aftermath of the US Supreme Court’s Alice decision can lead to some AI innovations being categorised as patent-ineligible “abstract ideas”. However, the European Patent Office (EPO) has a stable and long-established body of case law in the assessment of computer-implemented inventions via the problem-solution approach.

    We believe that the European approach can be helpful in navigating patent eligibility arguments in the US. We shall review useful practical examples from EPO case law of attempts to protect AI inventions.
  • The CRISPR IP Saga - the latest chapter and looking to the next Recorded: Oct 10 2019 67 mins
    Dr Claire Irvine (Partner, HGF), Douglas Drysdale (Partner, HGF)
    CRISPR gene-editing continues to hit the headlines regularly as a ground-breaking technology with many millions now flowing into companies seeking to exploit the technology in both the therapeutic and agricultural fields. Unfortunately, the IP landscape continues to lack clarity with possibility of divergence between Europe and the US.

    This webinar will provide an update on the CRISPR IP saga and seek to shine light on the interplay between the latest chapter in the US, starting with new interference proceedings instigated by the USPTO, and opposition and appeal proceedings affecting key European patents at the European Patent Office. With oral proceeding now scheduled for early February 2020 for the opposition to the basic European patent of the University of California et al. and availability of a non-binding preliminary opinion on the arguments from the opposition board, it is an apt time for review of the main focus of the battle - coverage of CRISPR/Cas9 gene-editing in eukaryotic cells. The webinar will also discuss the considerations for those needing to think about freedom-to–operate in the absence of resolution of a standard for CRISPR gene-editing for therapy and the growing number of
    claims outside the main battle lines.

    This webinar is aimed at those wishing to hear about the latest developments in the CRISPR IP landscape whether in the commercial, academic, legal or patent world. With the CRISPR IP saga not evidently close to the final chapter, it will also provide an opportunity to raise questions which may arise from the on–going lack of clarity.
Providing insight on Intellectual Property and the Life Sciences
Content for the home of World IP Review and Life Sciences IP Review

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: The Essential Value: IoT SEPs and the Case for Patent Pools
  • Live at: May 27 2020 3:00 pm
  • Presented by: Mathias Hellman (Ericsson), Luke McLeroy (Avanci), Timothy Berghuis (InterDigital), Tom Phillips (WIPR)
  • From:
Your email has been sent.
or close